1. Advances in prognostic biomarkers for esophageal cancer
   Wanli Yang et al, 2019, Expert Review of Molecular Diagnostics CrossRef
2. THUMP domain containing 2 protein possibly induces resistance to cisplatin and 5‐fluorouracil in in vitro human esophageal squamous cell carcinoma cells as revealed by transposon activation mutagenesis
   Masato Hayashi et al, 2019, The Journal of Gene Medicine CrossRef
3. Effect of 5-fluorouracil on cellular response to proton beam in esophageal cancer cell lines according to the position of spread-out Bragg peak
   Hidehiro Hojo et al, 2019, Acta Oncologica CrossRef
4. Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells
   Tomotaka Kato et al, 2021, PLOS ONE CrossRef
5. Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
   Anthi Maslarinou et al, 2023, Frontiers in Pharmacology CrossRef
6. Alternative enzymes as a special strategy for the adaptation of procaryotic organisms (Review)
   E. P. Ryzhkova, 2017, Applied Biochemistry and Microbiology CrossRef
7. Molecular mechanisms associated with chemoresistance in esophageal cancer
   Matheus Lohan-Codeço et al, 2022, Cellular and Molecular Life Sciences CrossRef
8. Combined effects of anticancer drugs and new synthetic α-methylene-δ-lactones on MCF-7 cells
   Katarzyna Gach et al, 2015, Tumor Biology CrossRef
9. Precision Medicine and Pancreatic Cancer
   James J. Farrell et al, 2016, Pancreas CrossRef